Unveiling the Oxytocin Crisis in India: A Detailed Examination of Its Rampant Misuse and Consequences.

Oxytocin, a hormone vital for childbirth and lactation, has found itself embroiled in a web of misuse across India and other countries. Healthcare providers have raised an alarm, shedding light on how this hormone, originally intended for medical purposes, is being extensively abused in various sectors. Here, we delve into five major industries where oxytocin misuse runs rampant in India and beyond.

Unveiling the Oxytocin Crisis in India: A Detailed Examination of Its Rampant Misuse and Consequences.

Dairy Industry: In the dairy sector, oxytocin is excessively used to extract more milk from cows and buffaloes. This hormone, when misused in animals, raises ethical concerns as it induces painful contractions in their uteruses. The pain inflicted upon these animals is inhumane. Moreover, the presence of oxytocin residues in milk can lead to health issues in humans, including nausea, early puberty, and fetal damage.

Illegal Use in Agriculture: Oxytocin has found its way into agriculture, where unscrupulous farmers employ it to artificially enhance the size of fruits and vegetables. This practice extends to various produce, including pumpkins, watermelons, brinjals, gourds, and cucumbers.

Misuse in Healthcare Centers: While oxytocin is intended to facilitate childbirth in healthcare settings, its misuse can alter the natural process of childbirth and result in severe health complications for both the child and mother.

Unlawful Induction of Early Puberty: Oxytocin, often referred to as the “love hormone,” profoundly affects social bonding. It is released during activities like hugging, kissing, and giving birth. Unregulated use of oxytocin can lead to early puberty in young girls, disrupting their physical and emotional development.

Health Ministry’s Response: Recognizing the gravity of the situation, the Central Drugs Standard Control Organisation (CDSCO) has issued a high alert to all states and Union Territories regarding oxytocin misuse. In 2014, the Indian government banned the retail sale of oxytocin injections. In April 2018, the Union Ministry of Health took significant steps to address the issue, implementing recommendations from CDSCO and DTAB (Drug Technical Advisory Board):

  • Manufacturing of oxytocin for domestic use is now restricted to the public sector.
  • All oxytocin products must display barcodes for tracking and traceability, curbing misuse.
  • Sales are limited to registered government hospitals and clinics, further ensuring tracking and preventing abuse.

These measures, though belated, aim to combat the widespread misuse of oxytocin. It is crucial for healthcare providers, policymakers, and society as a whole to remain vigilant and prioritize the responsible use of this essential hormone. The misuse of oxytocin not only jeopardizes health but also raises ethical concerns that demand immediate attention.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *